These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36625475)

  • 21. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J; Du H; Shen M; Zhao Z; Ye X
    J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
    Kim S; Hong J; Jeon R; Kim HS
    Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrative study of diet-induced mouse models of NAFLD identifies PPARα as a sexually dimorphic drug target.
    Smati S; Polizzi A; Fougerat A; Ellero-Simatos S; Blum Y; Lippi Y; Régnier M; Laroyenne A; Huillet M; Arif M; Zhang C; Lasserre F; Marrot A; Al Saati T; Wan J; Sommer C; Naylies C; Batut A; Lukowicz C; Fougeray T; Tramunt B; Dubot P; Smith L; Bertrand-Michel J; Hennuyer N; Pradere JP; Staels B; Burcelin R; Lenfant F; Arnal JF; Levade T; Gamet-Payrastre L; Lagarrigue S; Loiseau N; Lotersztajn S; Postic C; Wahli W; Bureau C; Guillaume M; Mardinoglu A; Montagner A; Gourdy P; Guillou H
    Gut; 2022 Apr; 71(4):807-821. PubMed ID: 33903148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice.
    Kant R; Lu CK; Nguyen HM; Hsiao HH; Chen CJ; Hsiao HP; Lin KJ; Fang CC; Yen CH
    Biomed Pharmacother; 2020 Sep; 129():110348. PubMed ID: 32554245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Western Diet-Induced Nonalcoholic Fatty Liver Disease Mice Mimic the Key Transcriptomic Signatures Observed in Humans.
    Ishigure T; Sasase T; Tohma M; Uno K; Toriniwa Y; Saito T; Saigo Y; Edamura K; Miyajima K; Ohta T
    Physiol Res; 2024 Aug; 73(4):593-608. PubMed ID: 39264080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.
    Yuan F; Wang H; Tian Y; Li Q; He L; Li N; Liu Z
    Lipids Health Dis; 2016 Feb; 15():20. PubMed ID: 26832365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
    Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
    J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gypenosides ameliorate high-fat diet-induced nonalcoholic fatty liver disease in mice by regulating lipid metabolism.
    Zhou T; Cao L; Du Y; Qin L; Lu Y; Zhang Q; He Y; Tan D
    PeerJ; 2023; 11():e15225. PubMed ID: 37065701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time-restricted feeding combined with resistance exercise prevents obesity and improves lipid metabolism in the liver of mice fed a high-fat diet.
    Damasceno de Lima R; Fudoli Lins Vieira R; Rosetto Muñoz V; Chaix A; Azevedo Macedo AP; Calheiros Antunes G; Felonato M; Rosseto Braga R; Castelo Branco Ramos Nakandakari S; Calais Gaspar R; Ramos da Silva AS; Esper Cintra D; Pereira de Moura L; Mekary RA; Rochete Ropelle E; Pauli JR
    Am J Physiol Endocrinol Metab; 2023 Nov; 325(5):E513-E528. PubMed ID: 37755454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.
    Teufel A; Itzel T; Erhart W; Brosch M; Wang XY; Kim YO; von Schönfels W; Herrmann A; Brückner S; Stickel F; Dufour JF; Chavakis T; Hellerbrand C; Spang R; Maass T; Becker T; Schreiber S; Schafmayer C; Schuppan D; Hampe J
    Gastroenterology; 2016 Sep; 151(3):513-525.e0. PubMed ID: 27318147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
    Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH
    Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Weight loss enhances hepatic antioxidant status in a NAFLD model induced by high-fat diet.
    Mendes IKS; Matsuura C; Aguila MB; Daleprane JB; Martins MA; Mury WV; Brunini TMC
    Appl Physiol Nutr Metab; 2018 Jan; 43(1):23-29. PubMed ID: 28834687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet.
    Jeong MJ; Kim SR; Jung UJ
    Nutr Res; 2019 Apr; 64():64-71. PubMed ID: 30802724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
    Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
    J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of LXR signaling by SULT2B1b promotes liver regeneration after partial hepatectomy in mouse models of nonalcoholic fatty liver disease.
    Zhang X; Xu Y; Bai Q; Li X; Han J; Hou Y; Ji Y; Zhang Z
    Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G87-G96. PubMed ID: 32475129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal obesogenic diet enhances cholestatic liver disease in offspring.
    Thompson MD; Hinrichs H; Faerber A; Tarr PI; Davidson NO
    J Lipid Res; 2022 May; 63(5):100205. PubMed ID: 35341737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.
    Luo Y; Burrington CM; Graff EC; Zhang J; Judd RL; Suksaranjit P; Kaewpoowat Q; Davenport SK; O'Neill AM; Greene MW
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E418-39. PubMed ID: 26670487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic ketogenic insufficiency reprograms hepatic glycogen metabolism and the lipidome.
    d'Avignon DA; Puchalska P; Ercal B; Chang Y; Martin SE; Graham MJ; Patti GJ; Han X; Crawford PA
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exocarpium Citri Grandis alleviates the aggravation of NAFLD by mitigating lipid accumulation and iron metabolism disorders.
    Deng G; Liu C; Zhao J; Wang M; Li Y; Yang M; Ye H; Li J; Qin M; Wu C; Shi H; Liao Y; Zhou Z; Zhang S; Lam Yung KK; Gao L
    J Ethnopharmacol; 2023 Sep; 313():116559. PubMed ID: 37116730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.